UNIVERSITY OF FLORIDA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1853-01-01

Employees: 10K

Market Cap: -

Website: http://www.ufl.edu

Clinical Trials

Spinal and Supra-Spinal Pain Mechanisms in Patients With Fibromyalgia

Completed

Conditions: Fibromyalgia
Pain

Interventions: Other: Vehicle Patch
Drug: Capsaicin Patch 8% or 0.1% Capsaicin Cream

First Posted Date: 2018-03-14

Last Posted Date: 2023-12-14

Lead Sponsor: University of Florida

Target Recruit Count: 55

Registration Number: NCT03464292

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease

Phase 2

Completed

Conditions: Nonalcoholic Fatty Liver Disease (NAFLD)
Type 2 Diabetes (T2DM)

Interventions: Drug: Lanifibranor
Other: Placebo

First Posted Date: 2018-03-08

Last Posted Date: 2024-03-29

Lead Sponsor: University of Florida

Target Recruit Count: 128

Registration Number: NCT03459079

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Effects of Exenatide on Motor Function and the Brain

Phase 1

Completed

Conditions: Parkinson's Disease

Interventions: Drug: Exenatide

First Posted Date: 2018-03-07

Last Posted Date: 2022-09-16

Lead Sponsor: University of Florida

Target Recruit Count: 5

Registration Number: NCT03456687

Locations: 🇺🇸
Laboratory for Rehabilitation Neuroscience, Gainesville, Florida, United States

iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic Syndromes

Not Applicable

Withdrawn

Conditions: Myelodysplastic Syndromes

Interventions: Drug: FDA-approved drug or combination of drugs
Drug: FLAG induction
Device: Computational biology simulations software
Drug: 7 + 3 induction
Drug: Low-dose cytarabine
Other: Supportive care alone

First Posted Date: 2018-02-27

Last Posted Date: 2019-06-11

Lead Sponsor: University of Florida

Registration Number: NCT03446638

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

The Absorption of Bioactive Berberine in Human

Not Applicable

Completed

Conditions: Healthy

Interventions: Dietary Supplement: Berberine
Dietary Supplement: TPGS emulsified berberine
Dietary Supplement: Quillaja extract emulsified berberine

First Posted Date: 2018-02-19

Last Posted Date: 2021-01-27

Lead Sponsor: University of Florida

Target Recruit Count: 32

Registration Number: NCT03438292

Locations: 🇺🇸
Food Science and human nutrition department at University of Florida, Gainesville, Florida, United States

Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI

Phase 4

Completed

Conditions: Coronary Artery Disease
Diabetes Mellitus, Type 2

Interventions: Drug: Ticagrelor
Drug: Clopidogrel

First Posted Date: 2018-02-19

Last Posted Date: 2021-11-30

Lead Sponsor: University of Florida

Target Recruit Count: 40

Registration Number: NCT03437044

Locations: 🇺🇸
University of Florida, Jacksonville, Florida, United States

Parent/Caregiver Conference Attendance Feasibility

Completed

Conditions: Health Knowledge, Attitudes, Practice

Interventions: Behavioral: Applicant Survey

First Posted Date: 2018-02-14

Last Posted Date: 2021-02-26

Lead Sponsor: University of Florida

Target Recruit Count: 84

Registration Number: NCT03432585

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Not Applicable

Not yet recruiting

Conditions: Human Papillomavirus (HPV) Vaccines

Interventions: Behavioral: Protect Me 4 Application + External Quality Improvement Support
Behavioral: Protect Me 4 Application Alone

First Posted Date: 2018-02-12

Last Posted Date: 2024-07-16

Lead Sponsor: University of Florida

Target Recruit Count: 1296

Registration Number: NCT03429413

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Health-Smart for Weight Loss at UF Jax Clinics

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Health Smart for Weight Loss

First Posted Date: 2018-02-01

Last Posted Date: 2024-10-17

Lead Sponsor: University of Florida

Target Recruit Count: 683

Registration Number: NCT03418701

Locations: 🇺🇸
UF Health Jacksonville Primary Care network, Jacksonville, Florida, United States

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Phase 4

Active, not recruiting

Conditions: Coronary Artery Disease

Interventions: Drug: High dose potent statin
Drug: ACE-I (lisinopril) or ARB (losartan)
Drug: Aspirin
Behavioral: Lifestyle Counseling
Behavioral: Quality of Life Questionnaires

First Posted Date: 2018-01-31

Last Posted Date: 2024-04-22

Lead Sponsor: University of Florida

Target Recruit Count: 2476

Registration Number: NCT03417388

Locations: 🇺🇸
Lutheran Health Physicians, Fort Wayne, Indiana, United States
🇺🇸
Silver State Cardiology, Henderson, Nevada, United States
🇺🇸
The Valley Hospital, Ridgewood, New Jersey, United States

and more 78 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy